AI-generated summary
The authors report a randomized, double-blind pilot trial of Vibradiofotology technology delivered by the Erectofix device in men with erectile dysfunction. Fifty-five patients were assigned to five weekly 45-minute sessions or to oral medication with sham laser, and the intervention group showed greater IIEF score improvements. The authors describe the technology as potentially safe and promising but note that further research is needed.
- Participants
- 55
- Who or what was studied
- Men diagnosed with erectile dysfunction
- Limits stated in the abstract
- The authors state that the study has limitations and that further research is required, and the abstract describes it as a pilot study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Control group, Pilot study, Photobiomodulation, Laser, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.